150 filings
Page 2 of 8
8-K
85h8aqsw207j99
15 May 23
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results
7:06am
ARS
yzblow
28 Apr 23
Annual report to shareholders
4:16pm
DEFA14A
4xkqnb54 v893ym1
28 Apr 23
Additional proxy soliciting materials
4:10pm
PRE 14A
lu1hh6
18 Apr 23
Preliminary proxy
4:05pm
8-K
dxqkoog 1g9o8i4
5 Apr 23
Departure of Directors or Certain Officers
8:13am
S-8
clrn 7eoq
9 Mar 23
Registration of securities for employees
8:27am
8-K
rg14ryadtedc4o3
9 Mar 23
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results
7:14am
8-K
8jrzvb buh
18 Jan 23
Fulcrum Therapeutics Announces Pricing of Upsized Public Offering of Common Stock
5:12pm
424B5
4406myc5
18 Jan 23
Prospectus supplement for primary offering
5:08pm
424B5
3bf6xz90pxob62xh
17 Jan 23
Prospectus supplement for primary offering
5:26pm
8-K
zm9l73c4nqtsg2cppdgz
17 Jan 23
Fulcrum Therapeutics Announces Proposed Public Offering of Common Stock
4:53pm
8-K
f8lf lwadzrwfsl1hx
4 Jan 23
Fulcrum Therapeutics Provides Business Update and 2023 Outlook
7:12am
8-K
rn5r 81hn
8 Nov 22
Fulcrum Therapeutics Announces Recent Business Highlights
7:36am
8-K
kgagnpex3649b tvyme
19 Oct 22
Departure of Directors or Certain Officers
4:06pm
8-K
bq61jp1 e5uea34
23 Aug 22
Other Events
4:58pm
8-K
kccs00ujw8acoptj
16 Aug 22
Fulcrum Therapeutics Announces Proposed Public Offering of Common Stock
5:59pm
424B5
kpkf 8lwx91pjqx
16 Aug 22
Prospectus supplement for primary offering
5:55pm